The START Center for Cancer Research announced the launch of the START Hope Hub, a digital platform providing access to over ...

V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine ...

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

Presented at ASCO 2025, new post-hoc analyses from the Phase III ARANOTE trial showed that darolutamide (Nubeqa) plus ADT ...

The results from ATOMIC trial, presented at ASCO 2025, show that adding atezolizumab (Tecentriq) to FOLFOX chemotherapy ...

ONCOLife presents an exclusive interview with Nick Slack, Chairman and CEO of The START Center for Cancer Research. In this session, we explore how the integration of the Carolina Urologic Research ...

We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...

AbbVie has announced plans to acquire Nimble Therapeutics in a $200 million deal. The acquisition brings Nimble’s pioneering oral peptide IL23R inhibitor, currently in preclinical development for ...

The Multidisciplinary Maze Oncology care today involves a constellation of specialists. According to the survey, cancer patients typically interact with at least five different providers throughout ...

The START Center for Cancer Research dosed the first U.S. patient in Moderna’s Phase 1 trial of mRNA-4106, a multivalent mRNA-based cancer vaccine targeting advanced solid tumors. The study evaluates ...

AnX Robotica announced that its AI-assisted tool for small bowel capsule endoscopy has received FDA clearance. With this approval, NaviCam ProScan becomes the first AI-assisted tool in its field. It ...